SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an

Related Keywords

Ohio State University ,Ohio ,United States ,Columbus ,Richard Gumina ,Joseph Bednash ,Linda Saif ,Daniel Jones ,Jeffrey Horowitz ,Eugene Oltz ,Shan Lu Liu ,Claire Carlin ,Julia Faraone ,Kai Xu ,Emily Caldwell ,Negin Goodarzi ,Rama Mallampalli ,Robertj Anthony Fund For Cardiovascular Research ,Ohio State Infectious Diseases Institute ,Ohio State Comprehensive Cancer Center ,National Center ,Translational Sciences ,Centers For Disease ,World Health Organization ,Ohio State College Of Veterinary Medicine ,Retrovirus Research ,Department Of Microbial Infection ,National Institutes Of Health ,Pathogens Program ,Veterinary Biosciences ,Ohio State ,Microbial Infection ,Disease Control ,Middle East ,Emerging Pathogens Program ,Infectious Diseases ,National Institutes ,Advancing Translational Sciences ,Glenn Barber Fellowship ,Veterinary Medicine ,Cardiovascular Research ,Comprehensive Cancer Center ,Yi Min Zheng ,Newswise ,Ovid 19 Sars Cov 2 Ba 86 Variant Omicron Neutralizing Antibodies Covid Vaccination Spike Protein Mutations Lung ,